- Supported exchanges /
- TWO /
- 4171.TWO
GeneReach Biotechnology (4171 TWO) stock market data APIs
GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers automatic nucleic acid extraction systems, prep homogenization system, and mini centrifuge equipment; and reagents and consumables, comprising human IVD assays, iiPCR specific reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and research reagents and consumables. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock. GeneReach Biotechnology Corp. was founded in 2004 and is headquartered in Taichung, Taiwan.
GeneReach Biotechnology Financial Data Overview
| 29.1 | |
| 28.8 | |
| - | |
| 29.15 | |
| 28.75 | |
| 25.85-47 | |
| 1 672 M | |
| 57 458 K | |
| 192 M | |
| -0.8117 | |
| 0.815 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
GeneReach Biotechnology Fundamental Data is available in our Financial Data APIs
- Net Revenue 192 M
- EBITDA -154 744 000
- Earnings Per Share -2.42
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get GeneReach Biotechnology Earnings via APIs
- Latest Release 2023-05-09
- EPS/Forecast NaN
Get GeneReach Biotechnology End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
